» Articles » PMID: 24612416

Plasmin Deficiency Leads to Fibrin Accumulation and a Compromised Inflammatory Response in the Mouse Brain

Overview
Publisher Elsevier
Specialty Hematology
Date 2014 Mar 12
PMID 24612416
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Excess fibrin in blood vessels is cleared by plasmin, the key proteolytic enzyme in fibrinolysis. Neurological disorders and head trauma can result in the disruption of the neurovasculature and the entry of fibrin and other blood components into the brain, which may contribute to further neurological dysfunction.

Objectives: While chronic fibrin deposition is often implicated in neurological disorders, the pathological contributions attributable specifically to fibrin have been difficult to ascertain. An animal model that spontaneously acquires fibrin deposits could allow researchers to better understand the impact of fibrin in neurological disorders.

Methods: Brains of plasminogen (plg)- and tissue plasminogen activator (tPA)-deficient mice were examined and characterized with regard to fibrin accumulation, vascular and neuronal health, and inflammation. Furthermore, the inflammatory response following intrahippocampal lipopolysaccharide (LPS) injection was compared between plg(-/-) and wild type (WT) mice.

Results And Conclusions: Both plg(-/-) and tPA(-/-) mice exhibited brain parenchymal fibrin deposits that appear to result from reduced neurovascular integrity. Markers of neuronal health and inflammation were not significantly affected by proximity to the vascular lesions. A compromised neuroinflammatory response was also observed in plg(-/-) compared to WT mice following intrahippocampal LPS injection. These results demonstrate that fibrin does not affect neuronal health in the absence of inflammation and suggest that plasmin may be necessary for a normal neuroinflammatory response in the mouse CNS.

Citing Articles

Cerebrospinal Fluid Proteomic Profiles in Patients with Postherpetic Neuralgia.

Chen K, Wang M, Long D, Zou D, Li X, Wang R J Proteome Res. 2023; 22(12):3879-3892.

PMID: 37966014 PMC: 10696610. DOI: 10.1021/acs.jproteome.3c00547.


New Wine in an Old Bottle: tPA for Ischemic Stroke Management.

She R, Ge J, Mei Z Transl Stroke Res. 2023; .

PMID: 37921975 DOI: 10.1007/s12975-023-01209-6.


The protective effect of early dietary fat consumption on Alzheimer's disease-related pathology and cognitive function in mice.

Amelianchik A, Merkel J, Palanisamy P, Kaneki S, Hyatt E, Norris E Alzheimers Dement (N Y). 2021; 7(1):e12173.

PMID: 34084889 PMC: 8144936. DOI: 10.1002/trc2.12173.


Effects of Thrombin on the Neurovascular Unit in Cerebral Ischemia.

Cao H, Seto S, Bhuyan D, Chan H, Song W Cell Mol Neurobiol. 2021; 42(4):973-984.

PMID: 33392917 PMC: 11441220. DOI: 10.1007/s10571-020-01019-6.


Anticoagulants for Treatment of Alzheimer's Disease.

Grossmann K J Alzheimers Dis. 2020; 77(4):1373-1382.

PMID: 32925057 PMC: 7683055. DOI: 10.3233/JAD-200610.


References
1.
DHaeseleer M, Cambron M, Vanopdenbosch L, De Keyser J . Vascular aspects of multiple sclerosis. Lancet Neurol. 2011; 10(7):657-66. DOI: 10.1016/S1474-4422(11)70105-3. View

2.
Ryu J, McLarnon J . A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med. 2008; 13(9A):2911-25. PMC: 4498946. DOI: 10.1111/j.1582-4934.2008.00434.x. View

3.
Adams R, Bauer J, Flick M, Sikorski S, Nuriel T, Lassmann H . The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med. 2007; 204(3):571-82. PMC: 2137908. DOI: 10.1084/jem.20061931. View

4.
Claudio L, Raine C, Brosnan C . Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol. 1995; 90(3):228-38. DOI: 10.1007/BF00296505. View

5.
Mosesson M . Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005; 3(8):1894-904. DOI: 10.1111/j.1538-7836.2005.01365.x. View